These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16639795)

  • 1. The buzz about bisphosphonates.
    Farrar SK
    LDA J; 2005; 64(3):27. PubMed ID: 16639795
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteonecrosis of the jaw and bisphosphonates.
    Durie BG; Katz M; Crowley J
    N Engl J Med; 2005 Jul; 353(1):99-102; discussion 99-102. PubMed ID: 16000365
    [No Abstract]   [Full Text] [Related]  

  • 3. Osteonecrosis of the jaw and bisphosphonates.
    Woo SB; Hande K; Richardson PG
    N Engl J Med; 2005 Jul; 353(1):99-102; discussion 99-102. PubMed ID: 16003837
    [No Abstract]   [Full Text] [Related]  

  • 4. Bisphosphonates and osteonecrosis of the jaw.
    Shenker NG; Jawad AS
    Rheumatology (Oxford); 2007 Jul; 46(7):1049-51. PubMed ID: 17500074
    [No Abstract]   [Full Text] [Related]  

  • 5. Bisphosphonates and avascular necrosis of the jaws.
    Carter GD; Goss AN
    Aust Dent J; 2003 Dec; 48(4):268. PubMed ID: 14738134
    [No Abstract]   [Full Text] [Related]  

  • 6. The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
    Kraj M; Pogłód R; Maj S; Owczarska K
    Acta Pol Pharm; 2006; 63(5):450-2. PubMed ID: 17357613
    [No Abstract]   [Full Text] [Related]  

  • 7. Bisphosphonate treatment as a cause of jaw osteonecrosis.
    Kanat O; Ozet A; Ataergin S; Kuzhan O; Arpaci F; Ozturk B; Komurcu S; Ozturk M
    Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?
    Junquera L; Gallego L
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1516-7. PubMed ID: 18571043
    [No Abstract]   [Full Text] [Related]  

  • 9. Jaw complications in breast and prostate cancer patients treated with zoledronic acid.
    Ortega C; Faggiuolo R; Vormola R; Montemurro F; Nanni D; Goia F; Aglietta M
    Acta Oncol; 2006; 45(2):216-7. PubMed ID: 16546871
    [No Abstract]   [Full Text] [Related]  

  • 10. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.
    Dimopoulos MA; Kastritis E; Anagnostopoulos A; Melakopoulos I; Gika D; Moulopoulos LA; Bamia C; Terpos E; Tsionos K; Bamias A
    Haematologica; 2006 Jul; 91(7):968-71. PubMed ID: 16757414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent reports link bisphosphonates use to osteonecrosis.
    Marunick M; Miller R; Gordon S
    Todays FDA; 2006 Mar; 18(3):26-31. PubMed ID: 16639805
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on osteonecrosis of the jaws and bisphosphonates.
    Chehade MJ
    Climacteric; 2007 Oct; 10(5):440-1. PubMed ID: 17852148
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral bisphosphonates and osteonecrosis of the jaw.
    Wynn RL
    Gen Dent; 2007; 55(1):8-10. PubMed ID: 17333956
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases.
    Smith A; Kressley A; Saif MW
    JOP; 2009 Mar; 10(2):212-4. PubMed ID: 19287122
    [No Abstract]   [Full Text] [Related]  

  • 15. Bisphosphonates, osteonecrosis of the jaw, and pharmacovigilance.
    Doogue M
    N Z Med J; 2006 Dec; 119(1246):U2334. PubMed ID: 17151708
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug induced osteonecrosis of the jaws.
    Weeda LW
    J Tenn Dent Assoc; 2006; 86(2):18-9. PubMed ID: 16895006
    [No Abstract]   [Full Text] [Related]  

  • 17. Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates.
    Bagán J; Blade J; Cozar JM; Constela M; García Sanz R; Gómez Veiga F; Lahuerta JJ; Lluch A; Massuti B; Morote J; San Miguel JF; Solsona E
    Med Oral Patol Oral Cir Bucal; 2007 Aug; 12(4):E336-40. PubMed ID: 17664922
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteonecrosis of the jaw and bisphosphonates.
    Khan A
    BMJ; 2010 Feb; 340():c246. PubMed ID: 20124367
    [No Abstract]   [Full Text] [Related]  

  • 19. Avascular necrosis of bone in leukemia and osteonecrosis of jaw by bisphosphonates.
    Nastro E; Allegra A; Oteri G; Ferlito S; Alonci A; Bellomo G; D'Angelo A; Tolomeo A; Cicciù D; De Ponte FS; Musolino C
    J Oral Maxillofac Surg; 2009 Dec; 67(12):2701-3. PubMed ID: 19926001
    [No Abstract]   [Full Text] [Related]  

  • 20. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?
    Brown JJ; Ramalingam L; Zacharin MR
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):863-7. PubMed ID: 18221397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.